CalciMedica, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported net loss was USD 34.36 million compared to USD 7.82 million a year ago. Basic loss per share from continuing operations was USD 7.66 compared to USD 111.16 a year ago.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
5.2 USD | -7.14% | -7.80% | +81.81% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+81.81% | 55.85M | |
+5.66% | 111B | |
+11.23% | 105B | |
-2.18% | 21.93B | |
-12.15% | 22.34B | |
-5.52% | 18.59B | |
-36.52% | 18.12B | |
-10.09% | 16.96B | |
+3.33% | 13.7B | |
+36.58% | 12.45B |
- Stock Market
- Equities
- CALC Stock
- News CalciMedica, Inc.
- CalciMedica, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023